Abstract
The reciprocal induction and worsening relationship between hypertension (HTN) and chronic kidney disease (CKD) is well known and investigated for a long time. Increased arterial stiffness is a major nontraditional cardiovascular risk factor in CKD reflecting the difficulty of the large arteries to convert flow oscillations into continuous blood flow due to significant morphological changes induced by this pathological condition. Surrogate markers of cardiovascular disease used in CKD work-up include ankle-brachial index, carotid ultrasound (assessing carotid intima-media thickness and plaque), aortic pulse wave velocity, and the echocardiography quantification of the subclinical hypertensive heart disease (e.g., left ventricular mass, diastolic dysfunction). Current data support the idea that the integration of clinical characteristics (accurate measurement of blood pressure, 24-h ambulatory blood pressure monitoring, etc.) with information derived from arterial stiffness assessment may represent an accurate and cost-effective approach for individualizing CKD and HTN patients’ care and treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amenos AC, Gonzalez-Juanatey JR, Gutierrez PC, Gilarranz AM, Costae CG. Prevalence of chronic kidney disease in patients with or at a high risk of cardiovascular disease. Rev Esp Cardiol. 2010;63(2):225–8.
Hallan SI, Dahl K, Oien CM, et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ. 2006;333(7577):1047.
Kes P, Milicić D, Basić-Jukić N. How to motivate nephrologists to think more “cardiac” and cardiologists to think more “renal”? Acta Med Croatica. 2011;65(Suppl 3):85–9.
Kheder-Elfekih R, Yannoutsos A, Blacher J, London GM, Safar ME. Hypertension and chronic kidney disease: respective contribution of mean and pulse pressure and arterial stiffness. J Hypertens. 2015;31:[Epub ahead of print].
Agarwal R, Martinez-Castelao A, Wiecek A, Massy Z, Suleymanlar G, Ortiz A, Blankestijn PJ, Covic A, Dekker FW, Jager KJ, Lindholm B, Goldsmith D, Fliser D, London G, Zoccali C. EUropean REnal and CArdiovascular medicine working group of the European renal association–European dialysis and transplant association (ERA–EDTA). The lingering dilemma of arterial pressure in CKD: what do we know, where do we go? Kidney Int Suppl. 2011;1(1):17–20.
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E, MD. 2014 evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.
Covic A, Goldsmith D, Donciu M-D, Siriopol D, Popa R, Kanbay M, London G. From profusion to confusion: the Saga of managing hypertension in chronic kidney disease! J Clin Hypertens. 2015;17(6):421–7.
Bangash F, Agarwal R. Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis. Clin J Am Soc Nephrol. 2009;4(3):656–64.
Rubin MF, Rosas SE, Chirinos JA, Townsend RR. Surrogate markers of cardiovascular disease in CKD: what’s under the hood? Am J Kidney Dis. 2011;57(3):488–97.
Covic A, Siriopol D. Pulse wave velocity ratio: the new “gold standard” for measuring arterial stiffness. Hypertension. 2015;65(2):289–90.
Boutouyrie P, Fliser D, Goldsmith D, Covic A, Wiecek A, Ortiz A, et al. Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European renal and cardiovascular medicine registry. Nephrol Dial Transplant. 2014;29(2):232–9.
Jia G, Aroor AR, Sowers JR. Arterial stiffness: a nexus between cardiac and renal disease. Cardiorenal Med. 2014;4:60–71.
Kullo IJ, Malik AR. Arterial ultrasonography and tonometry as adjuncts to cardiovascular risk stratification. J Am Coll Cardiol. 2007;49(13):1413–26.
Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H, on behalf of the European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588–605.
Reference Values for Arterial Stiffness’ Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’. Eur Heart J. 2010;31(19):2338–50.
Kalaitzidis RG, Karasavvidou DP, Tatsioni A, Pappas K, Katatsis G, Liontos A, Elisaf MS. Albuminuria as a marker of arterial stiffness in chronic kidney disease patients. World J Nephrol. 2015;4(3):406–14.
Fortier C, Mac-Way F, Desmeules S, Marquis K, De Serres SA, Lebel M, Boutouyrie P, Agharazii M. Aortic-brachial stiffness mismatch and mortality in dialysis population. Hypertension. 2015;65(2):378–84.
Ma Y, Zhou L, Dong J, Zhang X, Yan S. Arterial stiffness and increased cardiovascular risk in chronic kidney disease. Int Urol Nephrol. 2015;47(7):1157–64.
Hashimoto J, Ito S. Central pulse pressure and aortic stiffness determine renal hemodynamics. Pathophysiological implication for microalbuminuria in hypertension. Hypertension. 2011;58(5):839–46.
Dhaun N, Moorhouse R, MacIntyre IM, Melville V, Oosthuyzen W, Kimmitt RA, Brown KE, Kennedy ED, Goddard J, Webb DJ. Diurnal variation in blood pressure and arterial stiffness in chronic kidney disease. The role of endothelin-1. Hypertension. 2014;64(2):296–304.
Mojón A, Ayala D, Piñeiro L, Otero A, Crespo JJ, Moyá A, Bóveda J, de Lis JP, Fernández JR, Hermida RC, on behalf of the Hygia Project Investigators. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol Int. 2012;30(1–2):145–58.
Gismondi RA, Neves MF, Oigman W, Bregman R. Ambulatory arterial stiffness index is higher in hypertensive patients with chronic kidney disease. Int J Hypertens. 2012;2012:178078. doi:10.1155/2012/178078.
Elsurer R, Afsar B. Serum uric acid and arterial stiffness in hypertensive chronic kidney disease patients: sex-specific variations. Blood Press Monit. 2014;19(5):271–9.
Makris A, Seferou M, Papadopoulos DP. Resistant hypertension workup and approach to treatment. Int J Hypertens. 2011;2011:598694. doi:10.4061/2011/598694.
Bellasi A, Ferramosca E, Ratti C. Arterial stiffness in chronic kidney disease: the usefulness of a marker of vascular damage. Int J Nephrol. 2011;2011:734832. doi:10.4061/2011/734832.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Petriş, A.O. (2017). Secondary Causes: Work-Up and Its Specificities in CKD: Influence of Arterial Stiffening. In: Covic, A., Kanbay, M., Lerma, E. (eds) Resistant Hypertension in Chronic Kidney Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-56827-0_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-56827-0_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56825-6
Online ISBN: 978-3-319-56827-0
eBook Packages: MedicineMedicine (R0)